| Literature DB >> 18535205 |
Jason E Farrar1, Michelle Nater, Emi Caywood, Michael A McDevitt, Jeanne Kowalski, Clifford M Takemoto, C Conover Talbot, Paul Meltzer, Diane Esposito, Alan H Beggs, Hal E Schneider, Agnieszka Grabowska, Sarah E Ball, Edyta Niewiadomska, Colin A Sieff, Adrianna Vlachos, Eva Atsidaftos, Steven R Ellis, Jeffrey M Lipton, Hanna T Gazda, Robert J Arceci.
Abstract
Diamond-Blackfan anemia (DBA) is an inherited bone marrow failure syndrome characterized by anemia, congenital abnormalities, and cancer predisposition. Small ribosomal subunit genes RPS19, RPS24, and RPS17 are mutated in approximately one-third of patients. We used a candidate gene strategy combining high-resolution genomic mapping and gene expression microarray in the analysis of 2 DBA patients with chromosome 3q deletions to identify RPL35A as a potential DBA gene. Sequence analysis of a cohort of DBA probands confirmed involvement RPL35A in DBA. shRNA inhibition shows that Rpl35a is essential for maturation of 28S and 5.8S rRNAs, 60S subunit biogenesis, normal proliferation, and cell survival. Analysis of pre-rRNA processing in primary DBA lymphoblastoid cell lines demonstrated similar alterations of large ribosomal subunit rRNA in both RPL35A-mutated and some RPL35A wild-type patients, suggesting additional large ribosomal subunit gene defects are likely present in some cases of DBA. These data demonstrate that alterations of large ribosomal subunit proteins cause DBA and support the hypothesis that DBA is primarily the result of altered ribosomal function. The results also establish that haploinsufficiency of large ribosomal subunit proteins contributes to bone marrow failure and potentially cancer predisposition.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18535205 PMCID: PMC2518874 DOI: 10.1182/blood-2008-02-140012
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113